메뉴 건너뛰기




Volumn 10, Issue 2, 2009, Pages 93-99

Migraine strikes study: Factors in patients' decision to treat early

Author keywords

Early treatment; Headache; Migraine; Triptans

Indexed keywords

ANTIMIGRAINE AGENT; TRIPTAN DERIVATIVE;

EID: 62749202616     PISSN: 11292369     EISSN: 11292377     Source Type: Journal    
DOI: 10.1007/s10194-008-0091-1     Document Type: Article
Times cited : (5)

References (18)
  • 1
    • 0034883732 scopus 로고    scopus 로고
    • Prevalence and burden of migraine in the United States: Data from the American Migraine Study II
    • Lipton RB, Stewart WF, Diamond S, Diamond ML, Reed M (2001) Prevalence and burden of migraine in the United States: Data from the American Migraine Study II. Headache 41:646-657
    • (2001) Headache , vol.41 , pp. 646-657
    • Lipton, R.B.1    Stewart, W.F.2    Diamond, S.3    Diamond, M.L.4    Reed, M.5
  • 2
    • 33645733973 scopus 로고    scopus 로고
    • Validation of the classification of migraine with aura (IHS A1.1) proposed in ICHD-2
    • Kelman L (2005) Validation of the classification of migraine with aura (IHS A1.1) proposed in ICHD-2. Headache 45:1339-1344
    • (2005) Headache , vol.45 , pp. 1339-1344
    • Kelman, L.1
  • 4
    • 0035129715 scopus 로고    scopus 로고
    • Self-reported photophobic symptoms in migraineurs and controls are reliable and predict diagnostic category accurately
    • Mulleners WM, Aurora SK, Chronicle EP, Stewart R, Gopal S, Koehler PJ (2001) Self-reported photophobic symptoms in migraineurs and controls are reliable and predict diagnostic category accurately. Headache 41:31-39
    • (2001) Headache , vol.41 , pp. 31-39
    • Mulleners, W.M.1    Aurora, S.K.2    Chronicle, E.P.3    Stewart, R.4    Gopal, S.5    Koehler, P.J.6
  • 5
    • 0029120324 scopus 로고
    • Migraine symptoms: Results of a survey of self-reported migraineurs
    • Silberstein SD (1995) Migraine symptoms: Results of a survey of self-reported migraineurs. Headache 35:387-396
    • (1995) Headache , vol.35 , pp. 387-396
    • Silberstein, S.D.1
  • 7
    • 5444249664 scopus 로고    scopus 로고
    • The premonitory symptoms (prodrome): A tertiary care study of 893 migraineurs
    • Kelman L (2004) The premonitory symptoms (prodrome): A tertiary care study of 893 migraineurs. Headache 44:865-872
    • (2004) Headache , vol.44 , pp. 865-872
    • Kelman, L.1
  • 8
    • 42949145527 scopus 로고    scopus 로고
    • A review of the 5HT1B/1D agonist rizatriptan: Update on recent research and implications for the future
    • Mannix L (2008) A review of the 5HT1B/1D agonist rizatriptan: Update on recent research and implications for the future. Expert Opin Pharmacother 9:1001-1011
    • (2008) Expert Opin Pharmacother , vol.9 , pp. 1001-1011
    • Mannix, L.1
  • 9
    • 34250677785 scopus 로고    scopus 로고
    • Times to pain relief and pain freedom with rizatriptan 10 mg and other oral triptans
    • Ng-Mak DS, Hu XH, Chen Y, Ma L, Solomon G (2007) Times to pain relief and pain freedom with rizatriptan 10 mg and other oral triptans. Int J Clin Pract 61:1091-1111
    • (2007) Int J Clin Pract , vol.61 , pp. 1091-1111
    • Ng-Mak, D.S.1    Hu, X.H.2    Chen, Y.3    Ma, L.4    Solomon, G.5
  • 11
    • 0036166604 scopus 로고    scopus 로고
    • Treatment of migraine with rizatriptan: When to take the medication
    • On behalf of The United States Migraine Study Protocol (USMAP) Group
    • Hu XH, Raskin NH, Cowan R, Markson LE, Berger ML, On behalf of The United States Migraine Study Protocol (USMAP) Group (2002) Treatment of migraine with rizatriptan: When to take the medication. Headache 42:16-20
    • (2002) Headache , vol.42 , pp. 16-20
    • Hu, X.H.1    Raskin, N.H.2    Cowan, R.3    Markson, L.E.4    Berger, M.L.5
  • 12
    • 0033810275 scopus 로고    scopus 로고
    • Effect of early intervention with sumatriptan on migraine pain: Retrospective analyses of data from three clinical trials
    • Cady RK, Sheftell F, Lipton RB, O'Quinn S, Jones M, Putnam DG et al (2000) Effect of early intervention with sumatriptan on migraine pain: retrospective analyses of data from three clinical trials. Clin Ther 22:1035-1048
    • (2000) Clin Ther , vol.22 , pp. 1035-1048
    • Cady, R.K.1    Sheftell, F.2    Lipton, R.B.3    O'Quinn, S.4    Jones, M.5    Putnam, D.G.6
  • 14
    • 20544464115 scopus 로고    scopus 로고
    • Treating early versus treating mild: Timing of migraine prescription medications among patients with diagnosed migraine
    • Foley KA, Cady R, Martin V, Adelman J, Diamond M, Bell CF et al (2005) Treating early versus treating mild: Timing of migraine prescription medications among patients with diagnosed migraine. Headache 45:538-545
    • (2005) Headache , vol.45 , pp. 538-545
    • Foley, K.A.1    Cady, R.2    Martin, V.3    Adelman, J.4    Diamond, M.5    Bell, C.F.6
  • 15
    • 0037246651 scopus 로고    scopus 로고
    • Migraine medication attributes important for patient compliance: Concerns about side effects may delay treatment
    • Gallagher RM, Kunkel R (2003) Migraine medication attributes important for patient compliance: Concerns about side effects may delay treatment. Headache 43:36-43
    • (2003) Headache , vol.43 , pp. 36-43
    • Gallagher, R.M.1    Kunkel, R.2
  • 16
    • 17644364762 scopus 로고    scopus 로고
    • Has the prevalence of migraine and tension-type headache changed over a 12-year period? A Danish population survey
    • Lyngberg AC, Rasmussen BK, Jørgensen T, Jensen R (2005) Has the prevalence of migraine and tension-type headache changed over a 12-year period? A Danish population survey. Eur J Epidemiol 20:243-249
    • (2005) Eur J Epidemiol , vol.20 , pp. 243-249
    • Lyngberg, A.C.1    Rasmussen, B.K.2    Jørgensen, T.3    Jensen, R.4
  • 18
    • 33750452267 scopus 로고    scopus 로고
    • Evidence-based understanding of medication-overuse headache: Clinical implications
    • Dodick D, Freitag F (2006) Evidence-based understanding of medication-overuse headache: Clinical implications. Headache 46(Suppl 4):S202-S211
    • (2006) Headache , vol.46 , Issue.SUPPL. 4
    • Dodick, D.1    Freitag, F.2


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.